Thriving to the Finish Line
Hormone therapy has long been surrounded by caution, especially for women over 60. But what if the narrative we've accepted isn’t fully aligned with the data? In this Thrive Note, the conversation revisits one of the most influential studies in women’s health, the Women’s Health Initiative, and unpacks how its conclusions shaped decades of medical guidance. Dr. Anamaria Yeung and Dr. Rachel Coleman explore what the research actually showed versus how it was interpreted, highlighting a surprising reality: for many outcomes, hormone therapy did not increase risk in older women—and in some cases, offered meaningful benefits. From cardiovascular health to bone strength, sleep, and overall well-being, this discussion challenges long-held assumptions and opens the door to more nuanced, individualized decision-making. If you or someone you love is navigating menopause or post-menopausal health, this Thrive Note offers a fresh perspective grounded in data, not fear. 🎧 Listen to the full conversation with Dr. Rachel Coleman and Dr. Anamaria Yeung: https://youtu.be/uNS7fwmLGqM
16 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Thriving to the Finish Line community!